Anaphylactic Shock Due to Technetium (99mTc)-Tetrofosmin During Myocardial Perfusion Scintigraphy: A Case Report.

Autor:	Hashimoto S; Cardiology, Japan Community Healthcare Organization (JCHO) Kobe Central Hospital, Kobe, JPN., Tanaka T; Cardiology, Japan Community Healthcare Organization (JCHO) Kobe Central Hospital, Kobe, JPN., Shimoda Y; Cardiology, Japan Community Healthcare Organization (JCHO) Kobe Central Hospital, Kobe, JPN., Tanaka M; Cardiology, Japan Community Healthcare Organization (JCHO) Kobe Central Hospital, Kobe, JPN., Kondo M; Cardiology, Japan Community Healthcare Organization (JCHO) Kobe Central Hospital, Kobe, JPN.
Jazyk:	angličtina
Zdroj:	Cureus [Cureus] 2024 Jan 20; Vol. 16 (1), pp. e52644. Date of Electronic Publication: 2024 Jan 20 (Print Publication: 2024).
DOI:	10.7759/cureus.52644
Abstrakt:	Myocardial perfusion scintigraphy is a popular minimally invasive method for evaluating chronic coronary disease (CCD). We performed myocardial scintigraphy to assess CCD in a 74-year-old man with a history of allergy to contrast media. The patient developed anaphylactic shock immediately after the administration of the technetium ( 99m Tc)-tetrofosmin preparation. This is the first report of anaphylactic shock due to 99m Tc-tetrofosmin administration during myocardial perfusion scintigraphy. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2024, Hashimoto et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu